[PHARMA] QoQ TTM Result on 30-Jun-2011 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
10-Aug-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
30-Jun-2011 [#2]
Profit Trend
QoQ- -2.26%
YoY- -31.32%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
Revenue 1,582,398 1,520,981 1,529,311 1,492,216 1,446,116 1,378,348 1,326,138 12.48%
PBT 94,349 73,186 54,117 53,876 54,823 45,462 75,653 15.84%
Tax -28,102 -20,401 -15,466 -17,749 -18,223 -15,152 -21,273 20.37%
NP 66,247 52,785 38,651 36,127 36,600 30,310 54,380 14.05%
-
NP to SH 65,358 52,157 37,959 35,734 36,561 30,384 54,554 12.78%
-
Tax Rate 29.79% 27.88% 28.58% 32.94% 33.24% 33.33% 28.12% -
Total Cost 1,516,151 1,468,196 1,490,660 1,456,089 1,409,516 1,348,038 1,271,758 12.42%
-
Net Worth 474,161 514,153 464,092 451,517 437,661 421,262 424,488 7.64%
Dividend
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
Div 44,120 35,296 - - 50,261 50,261 89,852 -37.73%
Div Payout % 67.51% 67.67% - - 137.47% 165.42% 164.70% -
Equity
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
Net Worth 474,161 514,153 464,092 451,517 437,661 421,262 424,488 7.64%
NOSH 117,657 117,655 106,933 106,994 107,007 106,919 106,924 6.57%
Ratio Analysis
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
NP Margin 4.19% 3.47% 2.53% 2.42% 2.53% 2.20% 4.10% -
ROE 13.78% 10.14% 8.18% 7.91% 8.35% 7.21% 12.85% -
Per Share
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
RPS 1,344.91 1,292.74 1,430.15 1,394.66 1,351.41 1,289.15 1,240.26 5.54%
EPS 55.55 44.33 35.50 33.40 34.17 28.42 51.02 5.82%
DPS 37.50 30.00 0.00 0.00 47.00 47.00 84.00 -41.55%
NAPS 4.03 4.37 4.34 4.22 4.09 3.94 3.97 1.00%
Adjusted Per Share Value based on latest NOSH - 106,994
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
RPS 109.80 105.53 106.11 103.54 100.34 95.64 92.01 12.49%
EPS 4.53 3.62 2.63 2.48 2.54 2.11 3.79 12.61%
DPS 3.06 2.45 0.00 0.00 3.49 3.49 6.23 -37.72%
NAPS 0.329 0.3567 0.322 0.3133 0.3037 0.2923 0.2945 7.65%
Price Multiplier on Financial Quarter End Date
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
Date 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 30/09/10 -
Price 5.90 5.36 5.90 5.90 5.73 5.31 4.98 -
P/RPS 0.44 0.41 0.41 0.42 0.42 0.41 0.40 6.55%
P/EPS 10.62 12.09 16.62 17.67 16.77 18.69 9.76 5.78%
EY 9.42 8.27 6.02 5.66 5.96 5.35 10.25 -5.46%
DY 6.36 5.60 0.00 0.00 8.20 8.85 16.87 -47.78%
P/NAPS 1.46 1.23 1.36 1.40 1.40 1.35 1.25 10.89%
Price Multiplier on Announcement Date
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
Date 03/05/12 22/02/12 01/11/11 10/08/11 13/05/11 25/02/11 04/11/10 -
Price 5.90 5.90 5.90 5.90 5.05 5.35 4.92 -
P/RPS 0.44 0.46 0.41 0.42 0.37 0.42 0.40 6.55%
P/EPS 10.62 13.31 16.62 17.67 14.78 18.83 9.64 6.66%
EY 9.42 7.51 6.02 5.66 6.77 5.31 10.37 -6.19%
DY 6.36 5.08 0.00 0.00 9.31 8.79 17.07 -48.19%
P/NAPS 1.46 1.35 1.36 1.40 1.23 1.36 1.24 11.49%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment